Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,409 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01222221 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 1 | 45 | Cancer Research UKOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00550017 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) | terminated | Phase 1 / Phase 2 | 39 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00435084 | A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL | completed | Phase 1 / Phase 2 | 10 | Valerio TherapeuticsINDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02263950 | A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours(LON002-002) | unknown | Phase 1 / Phase 2 | 87 | LondonPharma Ltd.INDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00817518 | A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors | completed | Phase 1 | 145 | Hoffmann-La RocheINDUSTRY | 5 | Sep 2, 2015 | clinicaltrials |
| NCT00915408 | A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple Myeloma(CRD) | completed | Phase 1 / Phase 2 | 32 | King's College Hospital NHS TrustOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00421889 | A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment | completed | Phase 1 / Phase 2 | 80 | Valerio TherapeuticsINDUSTRY | 3 | Jul 28, 2015 | clinicaltrials |
| NCT00878722 | Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy | completed | Phase 1 / Phase 2 | 41 | Valerio TherapeuticsINDUSTRY | 3 | Jul 28, 2015 | clinicaltrials |
| NCT00878800 | A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas | completed | Phase 1 / Phase 2 | 41 | Valerio TherapeuticsINDUSTRY | 2 | Jul 28, 2015 | clinicaltrials |
| NCT00618722 | Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat(ATX-101) | completed | Phase 1 / Phase 2 | 85 | Kythera BiopharmaceuticalsINDUSTRY | 3 | Jul 14, 2015 | clinicaltrials |
| NCT00413075 | Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 121 | Valerio TherapeuticsINDUSTRY | 3 | Jul 8, 2015 | clinicaltrials |
| NCT01931761 | Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02145715 | Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma(MUKsix) | unknown | Phase 1 / Phase 2 | 54 | Prof Jamie CavenaghOTHER | 1 | Jun 26, 2015 | clinicaltrials |
| NCT02049190 | Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer | unknown | Phase 1 / Phase 2 | 75 | Arno TherapeuticsINDUSTRY | 1 | Jun 24, 2015 | clinicaltrials |
| NCT01326273 | Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation | withdrawn | Phase 1 / Phase 2 | 0 | Imperial College LondonOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01336478 | CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation | withdrawn | Phase 1 | 0 | Imperial College LondonOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01317212 | Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme | withdrawn | Phase 1 | 0 | North Bristol NHS TrustOTHER | 1 | Apr 17, 2015 | clinicaltrials |
| NCT01714037 | A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC](HALO) | terminated | Phase 1 | 82 | Debiopharm International SAINDUSTRY | 3 | Apr 8, 2015 | clinicaltrials |
| NCT01970553 | Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors | completed | Phase 1 | 47 | PharmaMarINDUSTRY | 2 | Apr 1, 2015 | clinicaltrials |
| NCT00346385 | BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 97 | ImmunoGen, Inc.INDUSTRY | 2 | Mar 26, 2015 | clinicaltrials |
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 6 | Cancer Research UKOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT00516607 | Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas | unknown | Phase 1 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Feb 10, 2015 | clinicaltrials |
| NCT02055716 | Sulforadex in Healthy Human Males MAD | completed | Phase 1 | 18 | Evgen PharmaINDUSTRY | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00710268 | Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours | completed | Phase 1 | 18 | AstraZenecaINDUSTRY | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01193595 | Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors | completed | Phase 1 | 39 | SanofiINDUSTRY | 3 | Dec 3, 2014 | clinicaltrials |
| NCT01431664 | AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia | completed | Phase 1 | 7 | Cancer Research UKOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01561911 | A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment | completed | Phase 1 | 29 | Cancer Research UKOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00056537 | ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer | completed | Phase 1 | 44 | Active Biotech ABINDUSTRY | 3 | Aug 27, 2014 | clinicaltrials |
| NCT00710515 | Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 2 | Aug 13, 2014 | clinicaltrials |
| NCT01279707 | Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)(MARALL) | unknown | Phase 1 / Phase 2 | 55 | Queen Mary University of LondonOTHER | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00265135 | A Study of CNTO 328 in Subjects With Metastatic Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 68 | Centocor, Inc.INDUSTRY | 4 | Jul 3, 2014 | clinicaltrials |
| NCT01354392 | AZD1152 in Diffuse Large B-cell Lymphoma | completed | Phase 1 / Phase 2 | 15 | Oxford University Hospitals NHS TrustOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00004207 | Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00973869 | Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery | unknown | Phase 1 | 30 | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT01222546 | Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Chugai Pharma Europe Ltd.INDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT01692262 | Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.(PYRUS) | completed | Phase 1 | 59 | AstraZenecaINDUSTRY | 2 | Jun 19, 2014 | clinicaltrials |
| NCT01872923 | Dose Escalating Study for Amphinex-based PCI of Bleomycin. | completed | Phase 1 | 3 | PCI Biotech ASINDUSTRY | 1 | Jun 16, 2014 | clinicaltrials |
| NCT01236144 | A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.(AML18 Pilot) | completed | Phase 1 / Phase 2 | 113 | Cardiff UniversityOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT01960374 | Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK | completed | Phase 1 | 117 | AstraZenecaINDUSTRY | 1 | Jun 2, 2014 | clinicaltrials |
| NCT00423124 | Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies | completed | Phase 1 / Phase 2 | 57 | AGC Biologics S.p.A.INDUSTRY | 5 | May 30, 2014 | clinicaltrials |
| NCT01581060 | Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | terminated | Phase 1 / Phase 2 | 41 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT01859351 | Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours | terminated | Phase 1 | 13 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT00841191 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | completed | Phase 1 / Phase 2 | 84 | Centocor, Inc.INDUSTRY | 5 | May 14, 2014 | clinicaltrials |
| NCT01816815 | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 | completed | Phase 1 | 73 | BayerINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT00915278 | A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors | terminated | Phase 1 | 33 | PfizerINDUSTRY | 2 | Apr 4, 2014 | clinicaltrials |
| NCT00473512 | A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy | completed | Phase 1 / Phase 2 | 54 | Cougar Biotechnology, Inc.INDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01352208 | Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients | terminated | Phase 1 / Phase 2 | 13 | Astellas Pharma IncINDUSTRY | 3 | Mar 24, 2014 | clinicaltrials |
| NCT01641575 | A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin | terminated | Phase 1 | 8 | Clovis Oncology, Inc.INDUSTRY | 2 | Mar 11, 2014 | clinicaltrials |
| NCT00113581 | Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer | completed | Phase 1 | 26 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials